Bespoke Extracts

Bespoke Extracts

Bespoke Extracts, Inc. originally incorporated to produce and market cannabis-infused consumables, leveraging the early-stage boom in regulated THC and CBD edibles. The company focused on branded product lines before the public markets punished the post-2018 cannabis selloff, cratering its share price and operational run-rate. By 2019, the entity was functionally a public shell — its original business wound down and its SEC reporting status became the remaining asset. Trans Global Group acquired Bespoke Extracts in 2019 and subsequently renamed the entire entity TGGI. The present-day strategy bears no resemblance to the original edible-manufacturing thesis. TGGI's regulatory filings describe the company as seeking acquisition targets, which suggests a blank-check posture, but there is no confirmed deployment into an operating business or investment portfolio. The structure is that of a public shell seeking a reverse merger rather than that of an investment firm. The company maintains its public listing and periodic SEC filings, giving it an active ticker but not an active business. TGGI's most recent disclosures focus on corporate housekeeping and forward-looking statements about merger searches. No team bios or operational investment mandates appear in the published record. There are no known portfolio companies, direct investments, or fund commitments attributable to the TGGI vehicle. Structurally, Bespoke Extracts / TGGI functions as a publicly traded shell with a history in cannabis and blockchain narrative pivots. This distinguishes it from traditional family offices — it has no permanent capital source, no identifiable principals managing a discretionary pool, and no investment track record beyond the search for a reverse-merger candidate. It exists as a regulatory entity, not an operating allocator.